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Abstract
Background: Cotyledonoid dissecting leiomyoma is a rare variant of uterine smooth muscle tumor with an unusual
growth pattern that shows intramural dissection within uterine myometrium and often a placenta-like appearance
in its extrauterine components.
Case presentation: We present a unique case of cotyledonoid dissecting leiomyoma with adenomyosis. A 40-year-old
Japanese female presented with prolonged menorrhagia and severe anemia. She had a pelvic mass followed-up for
6 years with a diagnosis of leiomyoma. However, increase in tumor size and cystic changes with hemorrhage
were found by magnetic resonance imaging, and total abdominal hysterectomy with bilateral salpingectomy
was performed. Macroscopically, the placenta-like exophytic mass protruding from the posterior uterine wall
was composed of multiple nodules containing numerous hemorrhagic cysts. The mass showed continuity as a
white multinodular dissecting mass infiltrating the posterolateral myometrium. Microscopically, both extra–and
intrauterine portions of the mass were composed of nodules that contained swirled neoplastic smooth muscle
cells with marked hyalinized degeneration, as observed in cotyledonoid dissecting leiomyomas of conventional
type. In addition, numerous non–neoplastic glands of endometrial type surrounded by abundant endometrium–like
stromal cells and non–neoplastic smooth muscle cells were found in the tumor, suggesting that it involved a part of
concomitant adenomyosis originating from the nontumoral myometrium.
Conclusions: Thus far, over 30 cases of cotyledonoid dissecting leiomyoma have been reported, none of which have
described the presence of adenomyosis within the tumor. The present case suggested that cotyledonoid dissecting
leiomyoma might have a unique clinical presentation involving concomitant uterine adenomyosis. It is critical for
pathologists, gynecologists, and radiologists to be cognizant of cotyledonoid dissecting leiomyoma variants for timely
and appropriate diagnosis and treatment.
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Background
Uterine leiomyomas are the most common type of uterine
tumor [1], with its variants accounting for approximately
10 % of cases [1]. Cotyledonoid dissecting leiomyoma is
an extremely rare variant of uterine leiomyoma with an
unusual pattern that is characterized by intramural dissec-
tion within the uterine corpus and often a placenta–like
macroscopic appearance of its extrauterine component
[2]. David et al. originally reported this variant as grape–
like leiomyoma in 1975 [3], which was later named as
cotyledonoid dissecting leiomyoma in a series of four cases
by Roth et al. [2]. Thereafter, over 30 cases have been
reported thus far; all followed a clinically benign course
[4–6]. Although several cases indicated coexisting focal
endometriosis, endosalpingiosis, and adenomyomatous
components [7–9], none showed obvious and abundant
nontumoral components within the tumor. Here we
present a unique case of cotyledonoid dissecting leiomyoma
involving numerous non-neoplastic endometrial glands
with endometrial stromal cells, indicating adenomyosis. To
the best of our knowledge, this is the first description of
cotyledonoid dissecting leiomyoma with ademomyosis.* Correspondence: sarikano@med.hokudai.ac.jp
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Case presentation
A 40-year-old Japanese female with gravidity 2 and par-
ity 2 presented with prolonged menorrhagia and severe
anemia. The patient had a history of cervical carcinoma
in situ and underwent cervical conization 10 years ago.
During postoperative follow-up, carcinoma did not recur,
but menorrhagia and anemia persisted. Six years before
admission, a uterine leiomyoma 3.5 cm in diameter was
confirmed by transvaginal ultrasound examination; the
tumor increased in size to 5 cm in diameter during evalu-
ation 2 years before admission. During the last year, an
extrauterine mass 5 cm in diameter protruding from
the posterior uterine wall was discovered. For further
assessment and treatment, the patient was admitted to
the gynecology department at our hospital. Magnetic
resonance imaging showed a large pelvic mass measuring
10 × 9 × 7 cm (Fig. 1a) containing hemorrhagic cysts. The
mass was located in the left posterolateral myometrial wall
with an extrauterine extension. Total abdominal hysterec-
tomy with bilateral salpingectomy was performed for sus-
picion of uterine sarcoma or degenerated leiomyoma.
Pathological findings
Macroscopically, the placenta-like extrauterine mass
measuring 10 × 9 × 9 cm was protruding from the poster-
ior uterine wall (Fig. 1b). This mass consisted of multiple
nodules with a deep red color giving it a placenta-like ap-
pearance and contained numerous hemorrhagic cysts
measuring up to 2 cm in diameter (Fig. 1c). The exophytic
mass showed continuity as a white dissecting multinodular
Fig. 1 Magnetic resonance imaging and gross appearance of the tumor. a Axial T2-weighted image shows a pelvic mass, measuring 10 × 9 × 7 cm,
located in the left posterolateral myometrial wall, with extrauterine extension to the pelvic cavity (arrowhead). b Macroscopically, a large exophytic
mass protruding from the posterior uterine wall into the pelvic cavity is observed. The mass contains multiple deep red multiple nodules, giving it a
placenta-like appearance. Uterine cervix is not affected (arrow). White line demonstrates the cut line shown on Fig. 1c. c The extrauterine mass
contains numerous hemorrhagic cysts. The extrauterine mass shows continuity as a white indistinct multinodular mass in the myometrium.
Endometrium is preserved (arrow)
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mass measuring 4 × 3 × 3 cm in the left lateral myometrial
wall (Fig. 1c and 2a). The rest of the myometrium was dif-
fusely thickened but did not contain any nodular lesions.
Histologically, both extra–and intrauterine components
of the mass consisted of numerous ill–defined nodules,
with nodules of the intrauterine component dissecting the
myometrium (Fig. 2b). All nodules exhibited sparsely
distributed swirls of benign smooth muscle cells, with
marked hyalinized degeneration and hydropic change
(Fig. 2b). The myocytes were uniform with slightly en-
larged and bland spindle–shaped nuclei and eosinophilic
cytoplasm (Fig. 2c). Mitotic figures, significant nuclear aty-
pia, and coagulative tumor necrosis suggesting malignancy
were not identified. Abundant collagen fibers were found
among myocyte fascicles (Fig. 2d). Numerous congested
and dilated vessels and edematous connective tissue be-
tween nodules were also found prominently in the extra-
uterine component of the mass. These macroscopic and
histologic features of the tumor were similar to those of
previously reported cases of cotyledonoid dissecting leio-
myoma of the uterus [2–4]. In addition, numerous glands
composed of columnar epithelium resembling endometrial
gland epithelium were surrounded by stromal cells with
features of endometrial stroma in both the extra-and
intrauterine tumor components. These glands were mark-
edly dilated in the extrauterine component and were con-
cordant with gross hemorrhagic cysts (Fig. 3a and d). The
endometrial gland-like columnar epithelial cells were non-
ciliated without cellular atypia (Fig. 3b), whereas the stro-
mal cells were diffusely positive for CD10 (monoclonal,
#56C6; Leica Biosystems, Newcastle, UK), an endometrial
stromal marker, by immunohistochemistry (Fig. 3c); these
findings were similar to the endometrial component of ade-
nomyosis. Interestingly, some of the glands were enclosed
by several layers of smooth muscle cells with myometrial
features (Fig. 4a). These smooth muscle cells were negative
to slightly positive for Bcl-2 (monoclonal, #124; DakoCyto-
mation, Glostrup, Denmark) by immunohistochemistry,
similar to that observed in tumor-free myometrium,
whereas Bcl-2 expression was abundant in leiomyoma cells
(Fig. 4b). In addition, ordinary adenomyosis was found in
the thickened and tumor-free myometrium (Fig. 3d). All to-
gether, these findings suggested that the glands found in
the tumor mass were part of the adenomyosis that were in-
vaded by tumor growth. Endometriosis was not found in
any other parts of the resected uterus or the fallopian tubes.
The patient showed no recurrence at 3 months of postop-
erative follow-up.
Fig. 2 Macroscopic and histopathological features of the tumor. a The intrauterine mass contains multiple nodules. b Both extra- and intrauterine
components parts consist of numerous ill-defined tumorous nodules, which dissect myometrium in the intrauterine part. All nodules show
sparsely distributed swirls of benign smooth muscle cells, with marked hyalinized degeneration, and hydropic change (hematoxylin-eosin staining;
object lens magnification, ×1.25). c The neoplastic smooth muscle cells are uniform, with spindle shaped nuclei and eosinophilic cytoplasm
(hematoxylin-eosin staining; object lens magnification, ×10). d Masson trichrome staining reveals abundant hyalinized collagen fibers admixed
with neoplastic myocyte fascicles in all nodules (object lens magnification, ×10)
Shimizu et al. Diagnostic Pathology  (2016) 11:69 Page 3 of 7
Discussion
In the present case, the clinical manifestation, gross ap-
pearance, and histological findings were in good agree-
ment with typical cotyledonoid dissecting leiomyoma.
Leiomyomas of the uterus are the most common uterine
tumor and usually affect women in their fourth and fifth
decades [1]. Most uterine leiomyomas are conventional
types, whereas variant forms comprise approximately
10 % of all leiomyoma cases [1]. Cotyledonoid dissecting
leiomyoma is an extremely rare variant of uterine leio-
myoma with an unusual growth pattern characterized by
an extrauterine mass that resembles a placenta and his-
tologically shows an intramural dissecting pattern in the
uterus [2, 3]. Saeed et al. reviewed 20 cases of cotyledo-
noid dissecting leiomyoma [4]. The ages of patients ranged
from 23 to 65 years (mean, 40.3 years), which were less
than those of patients with conventional leiomyomas. The
most common clinical presentation of this variant is a pel-
vic mass and is followed by abnormal uterine bleeding.
The size of these tumors ranged from 10 to 41 cm (mean,
17.7 cm). Thus far, over 30 cases have been reported in
the literature [4, 5]. Histologically, the neoplastic smooth
muscle cells form disorganized fascicles in cotyledonoid
dissecting leiomyomas, in contrast to the organized pat-
tern observed in conventional leiomyomas [6]. In this case,
both the intrauterine and extrauterine part of the tumor
was composed of the same nodular masses of disorganized
smooth muscle cells and collagen fibers as those of previ-
ous reports (Fig. 2c and d). All cases reported to date were
clinically benign, and only one case of recurrence after
partial tumorectomy was reported [10]. Cases of epitheli-
oid cotyledonoid dissecting leiomyoma variant [5] and
Fig. 3 Histopathological and immunohistochemical findings of cystic lesions of the tumor. a Cystic and dilated endometrial glands are present in
the extrauterine component, with degenerated blood inside (hematoxylin-eosin staining; object lens magnification, ×1.25). b The cyst is lined by
one layer of columnar cells that resemble endometrial epithelium without cellular atypia and is surrounded by stromal cells (hematoxylin-eosin
staining; object lens magnification, ×40). c The stromal cells are positive for CD10, an endometrial stromal marker (immunohistochemistry; object
lens magnification, ×10). d Lesions of cotyledonoid dissecting leiomyoma (yellow) and adenomyosis (red) are mapped in the gross specimen
shown in Fig. 1c, based on microscopic examination. Adenomyosis lesions are located not only in the extrauterine component but also in the
intrauterine tumor lesion and thickened tumor-free myometrium
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cotyledonoid dissecting leiomyoma with intravenous
leiomyomatosis [7] were also recently reported. How-
ever, neither an epithelioid pattern nor intravascular
tumor components were found in our case.
Interestingly, several reports alluded to cotyledonoid
dissecting leiomyomas with non-neoplastic cystic lesions
(Table 1). Conventional uterine leiomyoma does not usually
contain cystic lesions, whereas one case of intravenous
leiomyomatosis of the uterus with an endometrial compo-
nent was previously reported [11]. In addition, Fukunaga
et al. described a cotyledonoid dissecting leiomyoma with
limited foci of endometriosis in 1998 [8]; the foci were
located in the shallow portion of the extrauterine com-
ponents and the left ovary and were considered as endo-
metriosis. Conversely, Driss et al. reported a cotyledonoid
dissecting leiomyoma case associated with endosalpingiosis
Fig. 4 Histopathological findings and immunohistochemical staining of Bcl-2. a Left three quarters of the specimen show the tumor containing
endometrial glands and stromal cells surrounded by several layers of smooth muscle cells. Non-neoplastic myometrium is on the right quarter of
the specimen (hematoxylin-eosin staining; object lens magnification, ×2.5). b Negative to slightly positive Bcl-2 immunostaining is observed in
the surrounding layers of smooth muscle cells and tumor-free myometrium (right one quarter of the specimen), whereas Bcl-2 protein expression
in the cytoplasm of tumoral smooth muscle cells is abundant (immunohistochemistry; object lens magnification, ×2.5)
Table 1 Summary of all reported cases of cotyledonoid dissecting leiomyoma with non-neoplastic cystic lesions
Case Age Presentation Tumor location Size (cm) Other components Background References
1 35 Abdominal pain and mass Lateral wall 18 Endometriosis Endometriosis in
left ovary
[9]
2 47 Abdominal mass Posterior wall, broad ligaments,
pelvic cavity
25 Endosalpingiosis NA [10]
3a NA NA NA NA Adenoleiomyomatous
component
NA [8]
4 40 Menorrhagia and severe anemia Posterolateral wall, pelvic cavity 14 Adenomyosis Adenomyosis Present case
NA not available
aThe case was one of the six cotyledonoid dissecting leiomyoma cases in reference [7]
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in 2009 [9]. The lesion was within the exophytic compo-
nent with small cysts of 1–2 mm in diameter. These glands
and cysts were lined by ciliated tubal type epithelium and
surrounded by scanty, loose fibrous tissue. Immunohisto-
chemistry revealed that the columnar epithelium was posi-
tive for cytokeratin 7, but the stromal cells were not
characterized in detail. In a series of six cases, Jordan et al.
described one tumor demonstrating cystic spaces within
the extrauterine component [7]. They reported the pres-
ence of tubo-endometrial glands without accompanying
stroma; thus, that finding was interpreted as an unusual
adenoleiomyomatous element. The cotyledonoid dissecting
leiomyoma in our patient presented with the greatest extent
of non-neoplastic cystic lesions compared with the three
previous cases. However, all these cases, including ours,
suggest that cotyledonoid dissecting leiomyoma might have
a unique clinical presentation involving parts of benign
non-neoplastic cystic lesions.
We suppose the endometrial component in this tumor
may be a part of adenomyosis, not endometriosis. It is
because localization of the endometrial component is
not superficial and endometriosis is not found in any
part of the pelvic cavity. However, adenomyosis is dis-
tributed both in the tumor and tumor-free myometrium
(Fig. 3d). Furthermore, some of these endometrial ele-
ments within the tumor are enclosed by non-neoplastic
myometrial smooth muscle that is slightly immunoposi-
tive for Bcl-2 (Fig. 4a and b). Bcl-2 protein is known to
be an apoptosis-inhibiting gene product, and it is also
known to prevent apoptotic cell death in a variety of
cells. Matsuo et al. reported that Bcl-2 immunopositivity
was prominent in uterine leiomyoma cells and was
scarcely present in normal myometrial smooth muscle
cells [12]. They supposed that Bcl-2 protein associated
with progesterone is responsible for the growth of leio-
myomas by preventing apoptotic cell death [13].
On the other hand, adenomyoma should be an import-
ant differential diagnosis in the extrauterine part of the
tumor. Adenomyoma is one of the mixed epithelial and
mesenchymal tumors of the uterine corpus and is de-
scribed as a well-circumscribed tumor composed of
endometrial glands and endometrial-type stroma sur-
rounded by abundant smooth muscle component [1].
We cannot definitely distinguish adenomyoma with in-
volved adenomyosis in a cotyledonoid dissecting leio-
myoma, because each histological component is very
similar and also because of degenerative changes in the
extrauterine part caused by menstrual bleeding followed by
inflammation. Typical adenomyomas are intramural, firm,
and smooth-surfaced tumors [14]. They show gray-white
surfaces and are well demarcated from the myometrium on
cut sections, and their smooth muscle component shows
hypertrophy but does not make nodular proliferation
with collagen fibers [15]. However, we can also find a
few previous case reports of adenomyoma with promin-
ent cystic change extended to the pelvic cavity [16, 17].
Since histological analysis of these tumors is not provided
in detail, we cannot distinguish them from cotyledonoid
dissecting leiomyoma with adenomyosis. Accumulation of
similar cases will help us understand the nature and the
difference between adenomyoma and cotyledonoid dis-
secting leiomyoma with adenomyosis.
The mechanism of tumor development in this patient
is interesting. In this case, leiomyoma was first found in
the uterine wall by transvaginal ultrasonography and was
later noted to extend into the pelvic cavity. It is possible
that during tumor growth from the myometrium, endo-
metrial glands and stromal cells might have been captured
by the intramural component of tumor during its dissec-
tion through the surrounding adenomyosis, to be located
together with the extrauterine component. In this case,
glandular components and stromal cells were also rec-
ognized in the intramural component, supporting this
possibility. The cystic expansion of endometrial glands
outside the uterus might be correlated with loose con-
nective tissue with congestion and hydropic change.
The cotyledonoid dissecting leiomyoma in our case in-
cluded a large number of non-neoplastic cystic lesions
compared with previously reported three cases. This case
indicated that cotyledonoid dissecting leiomyoma could
occur with concomitant adenomyosis, depending on the
pattern of tumor growth. These four cases, including ours,
suggested that cotyledonoid dissecting leiomyoma might
have a unique presentation with benign non-neoplastic
cystic lesions, such as endometriosis, endosalpingiosis,
adenoleiomyomatous component, and adenomyosis.
Conclusions
The case presented herein is the first documented coty-
ledonoid dissecting leiomyoma with diffuse adenomyosis
and reveals a unique variant of cotyledonoid dissecting
leiomyoma involving benign cystic lesions. Accumula-
tion of similar case reports is expected and important.
While cotyledonoid dissecting leiomyoma has alarming
gross appearance with hemorrhagic cysts of adenomyosis
or other benign cystic lesions within the tumor mass, it
has a completely benign clinical course. Gynecologists,
radiologists, and pathologists should be cognizant of the
variance and nature of cotyledonoid dissecting leiomyo-
mas to avoid misdiagnosis and overtreatment.
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